M.D.C. Holdings's Return on Invested Capital Overview

According to Benzinga Pro data M.D.C. Holdings MDC posted a 44.75% decrease in earnings from Q3. Sales, however, increased by 5.41% over the previous quarter to $1.52 billion. Despite the increase in sales this quarter, the decrease in earnings may suggest M.D.C. Holdings is not utilizing their capital as effectively as possible. In Q3, M.D.C. Holdings earned $144.40 million and total sales reached $1.44 billion.

What Is Return On Invested Capital?

Earnings data without context is not clear and can difficult to base trading decisions on. Return on Invested Capital (ROIC) helps to filter signal from noise by measuring yearly pre-tax profit relative to invested capital by a business. Generally, a higher ROIC suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q4, M.D.C. Holdings posted an ROIC of 4.11%.

It is important to keep in mind that ROIC evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but does not account for factors that could affect earnings and sales in the near future.

ROIC is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROIC shows M.D.C. Holdings is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of invested capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For M.D.C. Holdings, the positive return on invested capital ratio of 4.11% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.

Upcoming Earnings Estimate

M.D.C. Holdings reported Q4 earnings per share at $1.08/share, which did not meet analyst predictions of $1.52/share.

This article was generated by Benzinga's automated content engine and reviewed by an editor.